{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:55:32Z","timestamp":1790751332166,"version":"4.1.0"},"reference-count":55,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Aging Neurosci."],"abstract":"<jats:p>\n                    Neuroinflammation represents a fundamental pathological mechanism underlying amnestic mild cognitive impairment (aMCI), with dysregulated activation of the complement system playing a pivotal role. Astrocyte-derived exosomes (ADEs), which are capable of traversing the blood-brain barrier (BBB), offer a non-invasive means to investigate central nervous system pathology. This study explored the diagnostic potential of two principal complement components, C4b and factor B (FB), within plasma-derived ADEs for aMCI and analyzed their interaction with the\n                    <jats:italic>ApoE<\/jats:italic>\n                    \u03b54 allele. We enrolled 99 aMCI patients and 96 demographically matched normal controls (NC). C4b and FB levels in plasma-derived ADEs were quantified using ELISA, and all participants underwent\n                    <jats:italic>ApoE<\/jats:italic>\n                    genotyping. In the total cohort, levels of both C4b and FB in ADEs were significantly elevated in the aMCI group compared to NC. Diagnostic model validation demonstrated that adding C4b alone or in combination with FB to a baseline model significantly improved diagnostic performance, whereas adding FB alone provided no significant benefit. Notably, the\n                    <jats:italic>ApoE<\/jats:italic>\n                    \u03b54 genotype exerted a precise modulatory effect: among\n                    <jats:italic>ApoE<\/jats:italic>\n                    \u03b54 non-carriers, C4b levels were elevated in the aMCI group but did not yield significant diagnostic improvement; in contrast, among\n                    <jats:italic>ApoE<\/jats:italic>\n                    \u03b54 carriers, both C4b and FB were specifically upregulated, and only their combination achieved excellent diagnostic performance (AUC = 0.833; DeLong's test,\n                    <jats:italic>P<\/jats:italic>\n                    = 0.017), whereas neither marker alone was effective. Furthermore, C4b exhibited broader and more significant correlations with cognitive function compared to FB. This study substantiates that ADE-derived C4b serves as a reliable diagnostic biomarker for aMCI, whereas the diagnostic efficacy of FB is contingent upon\n                    <jats:italic>ApoE<\/jats:italic>\n                    \u03b54 allele status. Consequently, we propose a precision diagnostic strategy that involves the concurrent assessment of C4b and FB specifically in individuals carrying the\n                    <jats:italic>ApoE<\/jats:italic>\n                    \u03b54 allele, thereby presenting a novel approach for the early detection of aMCI.\n                  <\/jats:p>","DOI":"10.3389\/fnagi.2026.1727449","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:00:39Z","timestamp":1790748039000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Complement C4b and factor B in astrocyte-derived exosomes as novel biomarkers for amnestic mild cognitive impairment"],"prefix":"10.3389","volume":"18","author":[{"given":"Yu","family":"Li","sequence":"first","affiliation":[{"name":"Department of Neurobiology, Xuanwu Hospital, Capital Medical University","place":["Beijing, China"]},{"name":"Beijing Geriatric Medical Research Center","place":["Beijing, China"]},{"name":"National Clinical Research Center for Geriatric Disorders","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menglu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Neurobiology, Xuanwu Hospital, Capital Medical University","place":["Beijing, China"]},{"name":"Beijing Geriatric Medical Research Center","place":["Beijing, China"]},{"name":"National Clinical Research Center for Geriatric Disorders","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Ying","sequence":"additional","affiliation":[{"name":"School of Rehabilitation and Exercise Health, Gannan Medical University, Ganzhou","place":["Jiangxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Han","sequence":"additional","affiliation":[{"name":"National Clinical Research Center for Geriatric Disorders, Xuanwu Hospital, Capital Medical University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qimeng","family":"Li","sequence":"additional","affiliation":[{"name":"Beijing Geriatric Medical Research Center","place":["Beijing, China"]},{"name":"Department of Clinical Biobank and Central Laboratory, Xuanwu Hospital, Capital Medical University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanning","family":"Cai","sequence":"additional","affiliation":[{"name":"Department of Neurobiology, Xuanwu Hospital, Capital Medical University","place":["Beijing, China"]},{"name":"Beijing Geriatric Medical Research Center","place":["Beijing, China"]},{"name":"National Clinical Research Center for Geriatric Disorders","place":["Beijing, China"]},{"name":"Department of Clinical Biobank and Central Laboratory, Xuanwu Hospital, Capital Medical University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"7411","DOI":"10.1002\/alz.14151","article-title":"Contribution of alpha-synuclein pathology to cerebral glucose metabolism in patients with amnestic MCI","volume":"20","author":"Abu-Rumeileh","year":"2024","journal-title":"Alzheimers Dement."},{"key":"B2","doi-asserted-by":"publisher","first-page":"111200","DOI":"10.1016\/j.celrep.2022.111200","article-title":"APOE4 drives inflammation in human astrocytes via TAGLN3 repression and NF-\u03baB activation","volume":"40","author":"Arnaud","year":"2022","journal-title":"Cell. Rep."},{"key":"B3","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41583-023-00776-9","article-title":"Cell type-specific roles of APOE4 in Alzheimer's disease","volume":"25","author":"Blumenfeld","year":"2024","journal-title":"Nat. Rev. Neurosci."},{"key":"B4","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3233\/JAD-140276","article-title":"Neuropsychological criteria for mild cognitive impairment improves diagnostic precision, biomarker associations, and progression rates","volume":"42","author":"Bondi","year":"2014","journal-title":"J. Alzheimers Dis."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1055050","DOI":"10.3389\/fimmu.2022.1055050","article-title":"Free complement and complement containing extracellular vesicles as potential biomarkers for neuroinflammatory and neurodegenerative disorders","volume":"13","author":"Burgelman","year":"2022","journal-title":"Front. Immunol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"e14375","DOI":"10.1002\/alz.14375","article-title":"Proteomic signatures of Alzheimer's disease and lewy body dementias: a comparative analysis","volume":"21","author":"Canal-Garcia","year":"2025","journal-title":"Alzheimers Dement."},{"key":"B7","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.bbi.2021.04.003","article-title":"Astrocytic Kir6.1 deletion aggravates neurodegeneration in the lipopolysaccharide-induced mouse model of Parkinson's disease via astrocyte-neuron cross talk through complement C3-C3R signaling","volume":"95","author":"Chen","year":"2021","journal-title":"Brain Behav. Immun."},{"key":"B8","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1146\/annurev-cellbio-101512-122326","article-title":"Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles","volume":"30","author":"Colombo","year":"2014","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1002\/alz.12629","article-title":"Mild cognitive impairment among rural-dwelling older adults in China: a community-based study","volume":"19","author":"Cong","year":"2023","journal-title":"Alzheimers Dement"},{"key":"B10","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/s41582-020-0400-0","article-title":"Complement in neurological disorders and emerging complement-targeted therapeutics","volume":"16","author":"Dalakas","year":"2020","journal-title":"Nat. Rev. Neurol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1038\/s41591-024-02931-w","article-title":"APOE4 homozygozity represents a distinct genetic form of Alzheimer's disease","volume":"30","author":"Fortea","year":"2024","journal-title":"Nat Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1038\/mp.2011.52","article-title":"APOE and Alzheimer disease: a major gene with semi-dominant inheritance","volume":"16","author":"Genin","year":"2011","journal-title":"Mol. Psychiat."},{"key":"B13","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1002\/ana.25172","article-title":"High complement levels in astrocyte-derived exosomes of Alzheimer's disease","volume":"83","author":"Goetzl","year":"2018","journal-title":"Ann. Neurol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"110667","DOI":"10.1016\/j.brainresbull.2023.110667","article-title":"Extracellular vesicles: a new communication paradigm of complement in neurological diseases","volume":"199","author":"Gu","year":"2023","journal-title":"Brain. Res. Bull."},{"key":"B15","doi-asserted-by":"publisher","first-page":"563","DOI":"10.3233\/JAD-240287","article-title":"Impact of preanalytical procedures on complement biomarkers in cerebrospinal fluid and plasma from controls and Alzheimer's disease patients","volume":"101","author":"Gutierrez","year":"2024","journal-title":"J. Alzheimers Dis."},{"key":"B16","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s13195-024-01507-7","article-title":"Updated safety results from phase 3 lecanemab study in early Alzheimer's disease","volume":"16","author":"Honig","year":"2024","journal-title":"Alzheimers Res. Ther."},{"key":"B17","doi-asserted-by":"publisher","first-page":"e661","DOI":"10.1016\/S2468-2667(20)30185-7","article-title":"Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults aged 60 years or older in China: a cross-sectional study","volume":"5","author":"Jia","year":"2020","journal-title":"Lancet. Pub. Health."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e1003597","DOI":"10.1371\/journal.pmed.1003597","article-title":"Association of APOE \u03b54 genotype and lifestyle with cognitive function among Chinese adults aged 80 years and older: a cross-sectional study","volume":"18","author":"Jin","year":"2021","journal-title":"PLoS. Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"eaau6977","DOI":"10.1126\/science.aau6977","article-title":"The biology, function, and biomedical applications of exosomes","volume":"367","author":"Kalluri","year":"2020","journal-title":"Science"},{"key":"B20","doi-asserted-by":"publisher","first-page":"102481","DOI":"10.1016\/j.arr.2024.102481","article-title":"Pathogenesis, diagnostics, and therapeutics for Alzheimer's disease: breaking the memory barrier","volume":"101","author":"Kamatham","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1537974","DOI":"10.3389\/fimmu.2025.1537974","article-title":"Factor B as a therapeutic target for the treatment of complement-mediated diseases","volume":"16","author":"Kavanagh","year":"2025","journal-title":"Front. Immunol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13024-024-00740-w","article-title":"Astrocytic autophagy plasticity modulates A\u03b2 clearance and cognitive function in Alzheimer's disease","volume":"19","author":"Kim","year":"2024","journal-title":"Mol. Neurodegener."},{"key":"B23","doi-asserted-by":"publisher","first-page":"5532","DOI":"10.1038\/s41380-019-0536-8","article-title":"The complement cascade in Alzheimer's disease: a systematic review and meta-analysis","volume":"26","author":"Krance","year":"2021","journal-title":"Mol. Psychiat."},{"key":"B24","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/jnc.15565","article-title":"Reactive astrogliosis: a friend or foe in the pathogenesis of Alzheimer's disease","volume":"164","author":"Kumar","year":"2023","journal-title":"J. Neurochem."},{"key":"B25","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1007\/s00415-025-13151-8","article-title":"Spatial navigation deficits in early Alzheimer's disease: the role of biomarkers and APOE genotype","volume":"272","author":"Lacz\u00f3","year":"2025","journal-title":"J. Neurol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.neuron.2014.11.018","article-title":"NF\u03baB-activated astroglial release of complement C3 compromises neuronal morphology and function associated with Alzheimer's disease","volume":"85","author":"Lian","year":"2015","journal-title":"Neuron"},{"key":"B27","doi-asserted-by":"publisher","first-page":"12919","DOI":"10.1038\/s41598-023-39890-0","article-title":"Disease-associated astrocytes and microglia markers are upregulated in mice fed high fat diet","volume":"13","author":"Lin","year":"2023","journal-title":"Sci. Rep."},{"key":"B28","doi-asserted-by":"publisher","first-page":"6793","DOI":"10.1002\/alz.14130","article-title":"The moderating role of information processing speed in the relationship between brain remodeling and episodic memory in amnestic mild cognitive impairment","volume":"20","author":"Ma","year":"2024","journal-title":"Alzheimers Dement."},{"key":"B29","doi-asserted-by":"publisher","first-page":"935","DOI":"10.2174\/156720512803251110","article-title":"Can apolipoproteins and complement factors be biomarkers of Alzheimer's disease?","volume":"9","author":"Manral","year":"2012","journal-title":"Curr. Alzheimer Res."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/j.neuron.2022.03.004","article-title":"ApoE Cascade Hypothesis in the pathogenesis of Alzheimer's disease and related dementias","volume":"110","author":"Martens","year":"2022","journal-title":"Neuron"},{"key":"B31","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.jalz.2019.03.007","article-title":"Inflammatory biomarkers in Alzheimer's disease plasma","volume":"15","author":"Morgan","year":"2019","journal-title":"Alzheimers Dement."},{"key":"B32","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1042\/CS20230513","article-title":"The complement system in neurodegenerative diseases","volume":"138","author":"Nimmo","year":"2024","journal-title":"Clin. Sci."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.3390\/cells9071618","article-title":"Astrocyte- and neuron-derived extracellular vesicles from Alzheimer's disease patients effect complement-mediated neurotoxicity","volume":"9","author":"Nogueras-Ortiz","year":"2020","journal-title":"Cells"},{"key":"B34","doi-asserted-by":"publisher","first-page":"101594","DOI":"10.1016\/j.smim.2022.101594","article-title":"APOE mediated neuroinflammation and neurodegeneration in Alzheimer's disease","volume":"59","author":"Parhizkar","year":"2022","journal-title":"Semin. Immunol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s00281-005-0004-1","article-title":"Emission of membrane vesicles: roles in complement resistance, immunity and cancer","volume":"27","author":"Pilzer","year":"2005","journal-title":"Springer Semin. Immunopathol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"137318","DOI":"10.1016\/j.neulet.2023.137318","article-title":"Complement proteins in serum astrocyte-derived exosomes are associated with mild cognitive impairment in type 1 diabetes mellitus patients","volume":"810","author":"Qi","year":"2023","journal-title":"Neurosci. Lett."},{"key":"B37","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13024-022-00574-4","article-title":"ApoE in Alzheimer's disease: pathophysiology and therapeutic strategies","volume":"17","author":"Raulin","year":"2022","journal-title":"Mol Neurodegener"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","article-title":"Alzheimer's disease","volume":"397","author":"Scheltens","year":"2021","journal-title":"Lancet"},{"key":"B39","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/S1474-4422(20)30412-9","article-title":"APOE and Alzheimer's disease: advances in genetics, pathophysiology, and therapeutic approaches","volume":"20","author":"Serrano-Pozo","year":"2021","journal-title":"Lancet. Neurol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"100057","DOI":"10.1016\/j.medp.2024.100057","article-title":"Blood-based biomarkers of Alzheimer's disease\u2014a guideline for clinical use","volume":"1","author":"Shi","year":"2024","journal-title":"Med. Plus"},{"key":"B41","doi-asserted-by":"publisher","first-page":"e12089","DOI":"10.1002\/jev2.12089","article-title":"Characterization of brain-derived extracellular vesicle lipids in Alzheimer's disease","volume":"10","author":"Su","year":"2021","journal-title":"J. Extracell. Vesicles."},{"key":"B42","doi-asserted-by":"publisher","first-page":"306","DOI":"10.4049\/jimmunol.1901068","article-title":"Complement-mediated events in Alzheimer's disease: mechanisms and potential therapeutic targets","volume":"204","author":"Tenner","year":"2020","journal-title":"J. Immunol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.jconrel.2020.04.017","article-title":"Astrocyte-derived extracellular vesicles: neuroreparative properties and role in the pathogenesis of neurodegenerative disorders","volume":"323","author":"Upadhya","year":"2020","journal-title":"J. Contr. Rel."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1170031","DOI":"10.3389\/fncel.2023.1170031","article-title":"Complement C4-deficient mice have a high mortality rate during PTZ-induced epileptic seizures, which correlates with cognitive problems and the deficiency in the expression of Egr1 and other immediate early genes","volume":"17","author":"Veremeyko","year":"2023","journal-title":"Front. Cell. Neurosci."},{"key":"B45","doi-asserted-by":"publisher","first-page":"e054347","DOI":"10.1136\/bmjopen-2021-054347","article-title":"Association of plasma apolipoproteins and levels of inflammation-related factors with different stages of Alzheimer's disease: a cross-sectional study","volume":"12","author":"Wang","year":"2022","journal-title":"BMJ Open"},{"key":"B46","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1159\/000354370","article-title":"Rate of conversion from prodromal Alzheimer's disease to Alzheimer's dementia: a systematic review of the literature","volume":"3","author":"Ward","year":"2013","journal-title":"Dement Geriatr. Cogn. Dis. Extra."},{"key":"B47","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.tcb.2023.09.004","article-title":"The cell biology of APOE in the brain","volume":"34","author":"Windham","year":"2023","journal-title":"Trends. Cell Biol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.dadm.2018.11.002","article-title":"Complement protein levels in plasma astrocyte-derived exosomes are abnormal in conversion from mild cognitive impairment to Alzheimer's disease dementia","volume":"11","author":"Winston","year":"2019","journal-title":"Alzheimers Dement."},{"key":"B49","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1016\/j.celrep.2019.07.060","article-title":"Complement C3 is activated in human AD brain and is required for neurodegeneration in mouse models of amyloidosis and tauopathy","volume":"28","author":"Wu","year":"2019","journal-title":"Cell Rep."},{"key":"B50","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s40035-022-00330-0","article-title":"Extracellular vesicles, from the pathogenesis to the therapy of neurodegenerative diseases","volume":"11","author":"Xia","year":"2022","journal-title":"Transl. Neurodegener."},{"key":"B51","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s13195-021-00864-x","article-title":"Plasma biomarker profiles and the correlation with cognitive function across the clinical spectrum of Alzheimer's disease","volume":"13","author":"Xiao","year":"2021","journal-title":"Alzheimers Res. Ther."},{"key":"B52","doi-asserted-by":"publisher","first-page":"8208","DOI":"10.3390\/ijms22158208","article-title":"Novel therapeutic approaches for Alzheimer's disease: an updated review","volume":"22","author":"Yu","year":"2021","journal-title":"Int. J Mol. Sci."},{"key":"B53","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1093\/brain\/awae278","article-title":"Brain-penetrant complement inhibition mitigates neurodegeneration in an Alzheimer's disease mouse model","volume":"148","author":"Zelek","year":"2025","journal-title":"Brain"},{"key":"B54","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.tips.2022.02.006","article-title":"Targeting complement in neurodegeneration: challenges, risks, and strategies","volume":"43","author":"Zelek","year":"2022","journal-title":"Trends. Pharmacol. Sci."},{"key":"B55","doi-asserted-by":"publisher","first-page":"303","DOI":"10.2174\/1567205013666161013091934","article-title":"Complement C4A and C4B gene copy number study in Alzheimer's disease patients","volume":"14","author":"Zorzetto","year":"2017","journal-title":"Curr. Alzheimer Res."}],"container-title":["Frontiers in Aging Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2026.1727449\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:00:41Z","timestamp":1790748041000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2026.1727449\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,30]]},"references-count":55,"alternative-id":["10.3389\/fnagi.2026.1727449"],"URL":"https:\/\/doi.org\/10.3389\/fnagi.2026.1727449","relation":{},"ISSN":["1663-4365"],"issn-type":[{"value":"1663-4365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,30]]},"article-number":"1727449"}}